Integrated Research Limited (IRI) AI Stock Analysis

• Market Cap: AU$59.60M
• Dividend Yield: 5.97%
• Average Volume (3M): 387.86K
• Price to Earnings (P/E): 4.4
• Beta (1Y): 1.07
• Revenue Growth: -18.05%
• EPS Growth: -51.45%
• Country: AU
• Employees: 142
• Sector: Technology
• Sector Strength: 88
• Industry: Software - Application
• EPS (TTM): 0.05
• Shares Outstanding: 180,591,800
• 10 Day Avg. Volume: 138,367
• 30 Day Avg. Volume: 387,860
• PEG Ratio: -0.11
• Price to Book (P/B): 0.74
• Price to Sales (P/S): 1.09
• P/FCF Ratio: 9.12
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: AU$0.40
• Price Target Upside: 17.65% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1
• EPS Forecast (FY): 0.03
• Revenue Forecast (FY): AU$73.10M

• Rating: 66 Neutral
• Price Target: AU$0.35 ▲(1.76% Upside)

Integrated Research Limited's stock score is primarily influenced by its strong valuation, with a low P/E ratio and high dividend yield suggesting potential undervaluation. However, mixed financial performance and bearish technical indicators weigh down the overall score.

Positive Factors

Strong Gross Profit Margins

High gross profit margins indicate effective cost management and pricing power, supporting long-term profitability and competitive positioning.

Stable Balance Sheet

A stable balance sheet with low leverage enhances financial flexibility, allowing the company to invest in growth opportunities and weather economic downturns.

Efficient Cash Conversion

Efficient conversion of net income to cash supports liquidity and the ability to fund operations, dividends, and strategic investments without relying on external financing.

Negative Factors

Declining Revenue Growth

Declining revenue growth can signal weakening demand or competitive pressures, potentially impacting future earnings and market share if not addressed.

Reduced Profitability Margins

Falling profitability margins suggest challenges in maintaining cost efficiency or pricing power, which can erode shareholder value over time.

Weakened Cash Flow Generation

Reduced cash flow generation limits the company's ability to reinvest in growth, pay down debt, or return capital to shareholders, potentially affecting long-term financial health.

Integrated Research Limited Business Overview & Revenue Model

Company Description

Integrated Research Limited (IRI) is a global technology company specializing in performance management and monitoring solutions for complex IT environments. The company operates primarily in the sectors of telecommunications, finance, and IT infrastructure, offering core products that include software solutions for analyzing and optimizing application performance, network performance, and service delivery. IRI's innovative technology helps organizations ensure high availability and reliability of their critical systems, enabling businesses to enhance customer experience and operational efficiency.

How the Company Makes Money

IRI generates revenue through a combination of software licensing, subscription services, and professional services. The company's key revenue streams include sales of its performance management software, which is offered both as perpetual licenses and as software-as-a-service (SaaS) subscriptions. Additionally, IRI earns income from consulting and support services, which help clients implement and optimize their solutions. Significant partnerships with major technology providers and telecommunications companies also contribute to its earnings, as these collaborations facilitate broader distribution and integration of IRI's products into clients' existing systems.

Integrated Research Limited Financial Statement Overview

Summary

Integrated Research Limited shows strong gross profit margins and a stable balance sheet with low leverage. However, declining revenue growth, reduced profitability margins, and weakened cash flow generation present challenges.

Income Statement

Integrated Research Limited has shown a decline in revenue growth with a negative rate of -4.25% in the latest year. Despite this, the company maintains strong gross profit margins at 100%, indicating efficient cost management. However, net profit margins have decreased from 32.57% to 19.57%, reflecting reduced profitability. The EBIT and EBITDA margins have also declined, suggesting operational challenges.

Balance Sheet

The company maintains a low debt-to-equity ratio of 0.018, indicating minimal leverage and financial stability. Return on equity has decreased from 30.70% to 13.28%, showing reduced efficiency in generating profits from shareholders' equity. The equity ratio remains strong, suggesting a solid capital structure.

Cash Flow

Free cash flow has decreased by 17.07%, indicating potential challenges in generating cash. The operating cash flow to net income ratio is 0.42, suggesting moderate cash generation from operations. The free cash flow to net income ratio is high at 0.94, indicating efficient conversion of net income to cash.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	68.26M	68.26M	83.29M	69.83M	62.87M	78.49M
Gross Profit	50.68M	68.26M	83.29M	28.94M	62.87M	78.49M
EBITDA	13.45M	13.45M	25.34M	-1.07M	10.40M	23.34M
Net Income	13.36M	13.36M	27.13M	-29.23M	1.54M	7.93M
Balance Sheet
Total Assets	122.97M	122.97M	114.19M	90.84M	132.20M	136.63M
Cash, Cash Equivalents and Short-Term Investments	40.59M	40.59M	31.89M	18.55M	12.33M	12.15M
Total Debt	1.85M	1.85M	1.72M	3.05M	4.87M	13.08M
Total Liabilities	22.36M	22.36M	25.82M	30.97M	45.08M	53.29M
Stockholders Equity	100.62M	100.62M	88.36M	59.87M	87.11M	83.34M
Cash Flow
Free Cash Flow	8.18M	8.18M	15.22M	8.20M	6.97M	9.67M
Operating Cash Flow	8.68M	8.68M	13.04M	15.99M	18.76M	21.91M
Investing Cash Flow	1.17M	4.12M	2.27M	-8.90M	-11.80M	-12.24M
Financing Cash Flow	-4.90M	-5.00M	-1.69M	-1.63M	-6.96M	-6.44M

Integrated Research Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.34
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:IRI, the sentiment is Negative. The current price of 0.34 is above the 20-day moving average (MA) of 0.34, above the 50-day MA of 0.34, and below the 200-day MA of 0.39, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 47.79 is Neutral, neither overbought nor oversold. The STOCH value of 23.81 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:IRI.

Integrated Research Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IRI	66 Neutral	AU$59.60M	4.37	13.76%	5.97%	-18.05%	-51.45%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
NVU	49 Neutral	AU$95.75M	―	―	―	―	―
AMX	48 Neutral	AU$25.65M	-3.97	-31.01%	―	-3.43%	-40.65%
PRO	41 Neutral	AU$10.33M	-1.70	-133.07%	―	-4.90%	-52.78%
FLX	41 Neutral	AU$47.76M	-6.90	―	―	21.82%	6.83%

Integrated Research Limited Corporate Events

Director Increases Stake in Integrated Research Limited

Integrated Research Limited announced a change in the director’s interest notice, revealing that Mr. Michael Hitz, a director of the company, has increased his indirect interest in the company by acquiring 149,500 ordinary shares through an on-market trade, bringing his total holdings to 300,000 shares. This acquisition could indicate confidence in the company’s future prospects and may impact stakeholder perceptions positively, reinforcing the company’s market position.

The most recent analyst rating on (AU:IRI) stock is a Hold with a A$0.35 price target. To see the full list of analyst forecasts on Integrated Research Limited stock, see the AU:IRI Stock Forecast page.

Integrated Research Limited Director Acquires Significant Shareholding

Integrated Research Limited announced a change in the director’s interest, with Mr. Michael Hitz acquiring 150,500 ordinary shares through on-market trades. This acquisition reflects a significant personal investment by Mr. Hitz, potentially indicating confidence in the company’s future prospects and stability, which may positively influence stakeholder perceptions.

The most recent analyst rating on (AU:IRI) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Integrated Research Limited stock, see the AU:IRI Stock Forecast page.

Integrated Research Limited Announces Director’s Share Acquisition

Integrated Research Limited has announced a change in the director’s interest, with Ms. Katherine Greenhill acquiring 90,000 ordinary shares through on-market trades. This acquisition, valued at $28,088.40, signifies a notable increase in Ms. Greenhill’s stake in the company, potentially impacting the company’s governance and shareholder dynamics.

The most recent analyst rating on (AU:IRI) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Integrated Research Limited stock, see the AU:IRI Stock Forecast page.

Integrated Research Limited’s AGM Resolutions Passed with Strong Support

At the 2025 Annual General Meeting of Integrated Research Limited, all resolutions were passed, including the remuneration report, the re-election of Mr. Michael Hitz, and the grant of performance rights to Mr. Ian Lowe. These outcomes reflect strong shareholder support and are likely to bolster the company’s governance and operational strategies, positively impacting its market position and stakeholder confidence.

The most recent analyst rating on (AU:IRI) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Integrated Research Limited stock, see the AU:IRI Stock Forecast page.

Integrated Research Highlights Strategic Focus at 2025 AGM

Integrated Research Limited announced the CEO’s presentation at the 2025 Annual General Meeting, highlighting its strategic focus on enhancing user experience and performance management solutions. The presentation underscores the company’s commitment to leveraging its hybrid cloud platform and domain expertise to optimize operations and improve system visibility for major global organizations, positioning IR as a key player in the industry.

The most recent analyst rating on (AU:IRI) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Integrated Research Limited stock, see the AU:IRI Stock Forecast page.

Integrated Research Limited Reports Solid Performance Amid Market Shifts

In its 2025 Annual General Meeting, Integrated Research Limited reported a solid profit performance despite challenges in customer renewals, supported by strong customer demand and cost management. The company maintains a robust balance sheet with no debt, allowing for strategic investments in innovation aimed at sustainable shareholder returns. The operating environment has shifted, with Microsoft dominating the small to mid-tier market in the Collaborate segment, prompting IR to focus on large enterprises with complex multi-vendor environments. Despite facing customer churn and market saturation in its legacy products, IR is committed to its product-led growth strategy to unlock new revenue streams and secure long-term growth.

The most recent analyst rating on (AU:IRI) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Integrated Research Limited stock, see the AU:IRI Stock Forecast page.

Integrated Research Projects EBITDA Loss Amid Product Growth Strategy

Integrated Research Limited has announced a trading update for the half-year ending December 2025, highlighting the momentum of its product-led growth strategy with increased investments and new product launches. Despite these efforts, the company anticipates softer revenue compared to the previous year due to weaker renewals and increased allowances for expected credit losses, leading to an expected EBITDA loss ranging from $3 million to $8 million.

The most recent analyst rating on (AU:IRI) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Integrated Research Limited stock, see the AU:IRI Stock Forecast page.

Integrated Research Limited Releases 2025 Annual Report

Integrated Research Limited has released its 2025 Annual Report, highlighting its continued focus on optimizing operations of mission-critical systems and enhancing user experience. The report underscores the company’s strategic positioning in the global market for performance management solutions, emphasizing its role in enabling seamless transactions and collaborations for major organizations worldwide.

The most recent analyst rating on (AU:IRI) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Integrated Research Limited stock, see the AU:IRI Stock Forecast page.